Pediatric Perfusion Products companies

  • Report ID: 2686
  • Published Date: Oct 06, 2025
  • Report Format: PDF, PPT

Key Pediatric Perfusion Products Market Players:

    The pediatric perfusion products market has technologically advanced players from the USA, Europe, and Asia – Pacific. These players innovate their products with safety and customization in mind for better pediatric cardiac intervention outcomes. Enhanced research and development (R&D) capabilities are also utilized through partnerships and mergers. To support cardiovascular intervention contracts, a growing incidence of pediatric cardiovascular disease will only benefit the increasing investments in healthcare infrastructure. A balance between the sophistication of product technology and affordability remains the greatest opportunity for market competitors interested in increasing market share and sustainable growth.

    Below is the list of some prominent players operating in the global market:

    • Medtronic plc
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • LivaNova PLC
    • Getinge AB
    • Terumo Corporation
    • MicroPort Scientific Corporation
    • Braile Biomédica
    • Chalice Medical Ltd.
    • Xenios AG
    • Eurosets S.r.l.
    • Nipro Corporation
    • MAQUET Holding B.V. & Co. KG.
    • Senko Medical Trading Co.
    • Tianjin Medical
    • Boston Children's Hospital
    • Vitalcor, Inc.
    • Andocor
    • Gish Biomedical, Inc.
    • JOTEC GmbH
    • Sorin Group
    • WeiGo Medical

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In 2025, the industry size of pediatric perfusion products is evaluated at USD 640.5 million.

Pediatric Perfusion Products Market size was valued at USD 640.5 million in 2025 and is projected to reach USD 1136.1 million by the end of 2035, rising at a CAGR of 5.9% during the forecast period, i.e., 2026-2035

The North America industry is predicted to account for the largest share of 36% by 2035, owing to the robust healthcare infrastructure and high volume of surgical procedures in the region.

The major players in the market are BioPerfusion Australia Pty Ltd, Seoul Medical Technologies, Indian HeartTech Pvt. Ltd., Malaysian CardioMed Solutions, CardioTech USA, MedEuropa Pharma AG, Innovate Perfusion Systems Ltd., Tokyo MedCare Corporation, BioCardia Solutions GmbH, HeartCare Technologies Inc., Asia MedTech Pvt Ltd, Pacific Perfusion Systems, K-Cardio Solutions, EuroPharma Medica, NewAge MedSystems Ltd., Tokyo Biomed Co., Ltd., MedAsia Healthcare
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos